Cargando…

Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition

Activating mutations in PTPN11, encoding the cytosolic protein tyrosine phosphatase SHP2, result in developmental disorders and act as oncogenic drivers in patients with hematologic cancers. The allosteric inhibitor SHP099 stabilizes the wild-type SHP2 enzyme in an autoinhibited conformation that is...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaRochelle, Jonathan R., Fodor, Michelle, Vemulapalli, Vidyasiri, Mohseni, Morvarid, Wang, Ping, Stams, Travis, LaMarche, Matthew J., Chopra, Rajiv, Acker, Michael G., Blacklow, Stephen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207684/ https://www.ncbi.nlm.nih.gov/pubmed/30375388 http://dx.doi.org/10.1038/s41467-018-06823-9

Ejemplares similares

Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling
por: Vemulapalli, Vidyasiri, et al.
Publicado: (2021)

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
por: Pfeiffer, Anamarija, et al.
Publicado: (2022)

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020)

Oxysterols are allosteric activators of the oncoprotein Smoothened
por: Nachtergaele, Sigrid, et al.
Publicado: (2012)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011)

Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
por: Pádua, Ricardo A. P., et al.
Publicado: (2018)

An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase
por: Anselmi, Massimiliano, et al.
Publicado: (2020)

Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2
por: Chio, Cynthia M., et al.
Publicado: (2014)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

More iPhone 3 Development: Tackling IPhone SDK 3
por: LaMarche, Jeff, et al.
Publicado: (2010)

Beginning iPhone 3 development: exploring the iPhone SDK
por: Mark, Dave, et al.
Publicado: (2009)

Beginning iPhone Development: Exploring the iPhone SDK
por: Mark, Dave, et al.
Publicado: (2008)

Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
por: Calligari, Paolo, et al.
Publicado: (2021)

Long-Range Charge Reorganization as an Allosteric Control Signal in Proteins
por: Banerjee-Ghosh, Koyel, et al.
Publicado: (2020)

Exploring the Distinct Binding and Activation Mechanisms for Different CagA Oncoproteins and SHP2 by Molecular Dynamics Simulations
por: Wang, Quan, et al.
Publicado: (2021)

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
por: Zhu, Yuyu, et al.
Publicado: (2021)

Substrates Modulate Charge-Reorganization Allosteric Effects in Protein–Protein Association
por: Ghosh, Shirsendu, et al.
Publicado: (2021)

Beginning iOS 5 development: exploring the iOS SDK
por: Mark, Dave, et al.
Publicado: (2011)

Beginning iPhone 4 Development: Exploring the IOS SDK
por: Nutting, Jack, et al.
Publicado: (2011)

The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2018)

Phosphotyrosine couples peptide binding and SHP2 activation via a dynamic allosteric network
por: Marasco, Michelangelo, et al.
Publicado: (2021)

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
por: Wang, Ye, et al.
Publicado: (2021)

Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
por: Gao, Jian, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
por: Ye, Wenjun, et al.
Publicado: (2022)

Crisis as the Catalyst for Meaningful Change
por: LaRochelle, Jeffrey S., et al.
Publicado: (2022)

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
por: Amante, Romain J., et al.
Publicado: (2023)

Using oriented peptide array libraries to evaluate methylarginine-specific antibodies and arginine methyltransferase substrate motifs
por: Gayatri, Sitaram, et al.
Publicado: (2016)

At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
por: LaRochelle, Joseph M., et al.
Publicado: (2020)

Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (Shp-1) P2 promoter by the HTLV-1 tax oncoprotein
por: Cheng, Jihua, et al.
Publicado: (2006)

Beginning iPhone development with Swift: exploring the iOS SDK
por: Marḳ, Daṿid, et al.
Publicado: (2014)

More iPhone development with Objective-C
por: Mark, Dave, et al.
Publicado: (2015)

Beginning iPhone development: exploring the iOS SDK
por: Mark, David, et al.
Publicado: (2014)

Pre-clerkship clinical skills and clinical reasoning course performance: Explaining the variance in clerkship performance: Pre-clerkship predictors of clerkship variance
por: LaRochelle, Jeffrey S., et al.
Publicado: (2016)

Theoretical lateral and axial sensitivity limits and choices of molecular reporters for Cherenkov-excited luminescence in tissue during x-ray beam scanning
por: LaRochelle, Ethan P. M., et al.
Publicado: (2020)

Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML
por: Popescu, Bogdan, et al.
Publicado: (2023)

Wearable Contactless Respiration Sensor Based on Multi-Material Fibers Integrated into Textile
por: Guay, Philippe, et al.
Publicado: (2017)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations
por: Wang, Quan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2sqah0qidhdmmtcuugp4ga6a30